Keywords: davanat/5-fu, phase, ii, clinical, trial, initiated, drugmaker

DAVANAT/5-FU Phase II clinical trial initiated

Article | 05 September 2005

Print This

US drugmaker Pro Pharmaceuticals says it has dosed the first colorectal cancer patient in a Phase II clinical trial of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in